DOI: 10.1055/s-00050348

Indian Journal of Medical and Paediatric Oncology

References

Mavroudis D, Saloustros E, Malamos N. et al Breast Cancer Investigators of Hellenic Oncology Research Group (HORG), Athens, Greece.
Six versus 12 months of adjuvant trastuzumab in combination with dose-dense chemotherapy for women with HER2-positive breast cancer: a multicenter randomized study by the Hellenic Oncology Research Group (HORG.

Ann Oncol 2015;
26 (07) 1333-1340

Download Bibliographical Data

Access:
Access: